Inhibitor development in previously untreated patients with severe haemophilia: A comparison of included patients and outcomes between a clinical study and a registry-based study

MLA

CTM & Statistical consultation, et al. Inhibitor Development in Previously Untreated Patients with Severe Haemophilia: A Comparison of Included Patients and Outcomes between a Clinical Study and a Registry-Based Study. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1432112956&authtype=sso&custid=ns315887.

APA

CTM & Statistical consultation, Directie Raad van Bestuur, Circulatory Health, Cardiovasculaire Epi Team 1, Jonker, C. J., Oude Rengerink, K., Hoes, A. W., Mol, P. G. M., & van den Berg, H. M. (2020). Inhibitor development in previously untreated patients with severe haemophilia: A comparison of included patients and outcomes between a clinical study and a registry-based study.

Chicago

CTM & Statistical consultation, Directie Raad van Bestuur, Circulatory Health, Cardiovasculaire Epi Team 1, Carla J Jonker, Katrien Oude Rengerink, Arno W Hoes, Peter G M Mol, and H Marijke van den Berg. 2020. “Inhibitor Development in Previously Untreated Patients with Severe Haemophilia: A Comparison of Included Patients and Outcomes between a Clinical Study and a Registry-Based Study.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1432112956&authtype=sso&custid=ns315887.